Organization
Nektar Therapeutics
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Nektar Therapeutics
... financial news website Calcalist. The drugmaker employs nearly 6,900 workers in Israel. Nektar Therapeutics – An experimental pneumonia treatment developed by Nektar and partner Bayer ...
... Nektar Therapeutics (Nasdaq: NKTR) announced today several promotions on its executive leadership team: Stephen ...
... today announced preclinical data of its neoantigen-based cancer vaccine in combination with Nektar Therapeutics' NKTR-214, a CD122-biased cytokine agonist which is currently in clinical trials. ...
... Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at ...
... Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that new clinical data will be presented for ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced it is presenting preclinical data on NKTR-358, a ...
... Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended ...
... If you want a Stock Review on NKTR, OPHT, PTCT, or ONCE then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... Labrucherie is currently Senior Vice President and Chief Financial Officer (CFO) of Nektar Therapeutics. Nevan Elam, Chairman and Chief Executive Officer stated, "Gil is a ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that Jeff Ajer, Executive Vice President and Chief ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that new data across its wholly-owned immuno-oncology (I-O) ...
... the waist. Try to keep your leg and upper body parallel. 2. Inhale and bend your right knee lower. Exhale and stand straighter, though be ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that it has begun dosing in the PROPEL ...
... Nektar Therapeutics (Nasdaq: NKTR) today presented clinical data from the SUMMIT-07 Phase 3 study ...
... Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled ...
... 6 percent but settled back and was up 3.4 percent Thursday, while Nektar Therapeutics, which is developing similar immunotherapy drugs, rose nearly 8 percent. An ...
... Nektar Therapeutics (Nasdaq: NKTR) will present clinical data from the SUMMIT-07 Phase 3 efficacy ...
... Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended ...
... Dr. Michael A. Eldon, the former Vice President of Clinical Pharmacology at Nektar Therapeutics, and a clinical pharmacology, pharmacokinetics/pharmacodynamics and pharmacometrics expert with more than ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤